skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Next-Generation Sequencing Reveals Regional Differences of the α-Synuclein Methylation State Independent of Lewy Body Disease
Next-Generation Sequencing Reveals Regional Differences of the α-Synuclein Methylation State Independent of Lewy Body Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Next-Generation Sequencing Reveals Regional Differences of the α-Synuclein Methylation State Independent of Lewy Body Disease

de Boni, L. ; Tierling, S. ; Roeber, S. ; Walter, J. ; Giese, A. ; Kretzschmar, Hans A.

Neuromolecular medicine, 2011-12, Vol.13 (4), p.310-320 [Periódico revisado por pares]

New York: Humana Press Inc

Texto completo disponível

Citações Citado por
2
Molecular biological identification of fungal pathogens in FFPE tissue from cases of cephalic mycosis
Molecular biological identification of fungal pathogens in FFPE tissue from cases of cephalic mycosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular biological identification of fungal pathogens in FFPE tissue from cases of cephalic mycosis

Bernhardt, A ; de Boni, L ; Kretzschmar, H A ; Tintelnot, K

Der Pathologe, 2013-11, Vol.34 (6), p.540-547

Germany

Texto completo disponível

Citações Citado por
3
Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study
Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study

RUGGE, M. ; DE BONI, M. ; PENNELLI, G. ; DE BONA, M. ; GIACOMELLI, L. ; FASSAN, M. ; BASSO, D. ; PLEBANI, M. ; GRAHAM, D. Y.

Alimentary pharmacology & therapeutics, 2010-05, Vol.31 (10), p.1104-1111 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

Banerji, Udai, Prof ; van Herpen, Carla M L, Prof ; Saura, Cristina, MD ; Thistlethwaite, Fiona, MD ; Lord, Simon, MD ; Moreno, Victor, MD ; Macpherson, Iain R, MD ; Boni, Valentina, MD ; Rolfo, Christian, Prof ; de Vries, Elisabeth G E, Prof ; Rottey, Sylvie, Prof ; Geenen, Jill, MD ; Eskens, Ferry, MD ; Gil-Martin, Marta, MD ; Mommers, Ellen C, PhD ; Koper, Norbert P, PhD ; Aftimos, Philippe, MD

The lancet oncology, 2019-08, Vol.20 (8), p.1124-1135 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

André, Thierry ; Boni, Corrado ; Mounedji-Boudiaf, Lamia ; Navarro, Matilde ; Tabernero, Josep ; Hickish, Tamas ; Topham, Clare ; Zaninelli, Marta ; Clingan, Philip ; Bridgewater, John ; Tabah-Fisch, Isabelle ; de Gramont, Aimery

The New England journal of medicine, 2004-06, Vol.350 (23), p.2343-2351 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
6
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Del Mastro, Lucia, Dr ; De Placido, Sabino, Prof ; Bruzzi, Paolo, MD ; De Laurentiis, Michele, MD ; Boni, Corrado, MD ; Cavazzini, Giovanna, MD ; Durando, Antonio, MD ; Turletti, Anna, MD ; Nisticò, Cecilia, MD ; Valle, Enrichetta, MD ; Garrone, Ornella, MD ; Puglisi, Fabio, MD ; Montemurro, Filippo, MD ; Barni, Sandro, MD ; Ardizzoni, Andrea, MD ; Gamucci, Teresa, MD ; Colantuoni, Giuseppe, MD ; Giuliano, Mario, MD ; Gravina, Adriano, MD ; Papaldo, Paola, MD ; Bighin, Claudia, MD ; Bisagni, Giancarlo, MD ; Forestieri, Valeria, MD ; Cognetti, Francesco, MD

The Lancet (British edition), 2015-05, Vol.385 (9980), p.1863-1872 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Solomon, Benjamin J ; Mok, Tony ; Kim, Dong-Wan ; Wu, Yi-Long ; Nakagawa, Kazuhiko ; Mekhail, Tarek ; Felip, Enriqueta ; Cappuzzo, Federico ; Paolini, Jolanda ; Usari, Tiziana ; Iyer, Shrividya ; Reisman, Arlene ; Wilner, Keith D ; Tursi, Jennifer ; Blackhall, Fiona

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

Pressiani, T. ; Boni, C. ; Rimassa, L. ; Labianca, R. ; Fagiuoli, S. ; Salvagni, S. ; Ferrari, D. ; Cortesi, E. ; Porta, C. ; Mucciarini, C. ; Latini, L. ; Carnaghi, C. ; Banzi, M. ; Fanello, S. ; De Giorgio, M. ; Lutman, F.R. ; Torzilli, G. ; Tommasini, M.A. ; Ceriani, R. ; Covini, G. ; Tronconi, M.C. ; Giordano, L. ; Locopo, N. ; Naimo, S. ; Santoro, A.

Annals of oncology, 2013-02, Vol.24 (2), p.406-411 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abiraterone and Increased Survival in Metastatic Prostate Cancer

de Bono, Johann S ; Logothetis, Christopher J ; Molina, Arturo ; Fizazi, Karim ; North, Scott ; Chu, Luis ; Chi, Kim N ; Jones, Robert J ; Goodman, Oscar B ; Saad, Fred ; Staffurth, John N ; Mainwaring, Paul ; Harland, Stephen ; Flaig, Thomas W ; Hutson, Thomas E ; Cheng, Tina ; Patterson, Helen ; Hainsworth, John D ; Ryan, Charles J ; Sternberg, Cora N ; Ellard, Susan L ; Fléchon, Aude ; Saleh, Mansoor ; Scholz, Mark ; Efstathiou, Eleni ; Zivi, Andrea ; Bianchini, Diletta ; Loriot, Yohann ; Chieffo, Nicole ; Kheoh, Thian ; Haqq, Christopher M ; Scher, Howard I

The New England journal of medicine, 2011-05, Vol.364 (21), p.1995-2005 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Fizazi, Karim, Prof Dr ; Scher, Howard I, Prof ; Molina, Arturo, MD ; Logothetis, Christopher J, Prof ; Chi, Kim N, MD ; Jones, Robert J, PhD ; Staffurth, John N, MD ; North, Scott, MD ; Vogelzang, Nicholas J, MD ; Saad, Fred, Prof ; Mainwaring, Paul, MD ; Harland, Stephen, MD ; Goodman, Oscar B, MD ; Sternberg, Cora N, MD ; Li, Jin Hui, PhD ; Kheoh, Thian, PhD ; Haqq, Christopher M, MD ; de Bono, Johann S, Prof

The lancet oncology, 2012-10, Vol.13 (10), p.983-992 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (81)

Data de Publicação 

De até
Refinar
  1. Antes de1998  (6)
  2. 1998Até2003  (11)
  3. 2004Até2010  (19)
  4. 2011Até2016  (40)
  5. Após 2016  (9)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (82)
  2. Japonês  (18)
  3. Italiano  (1)
  4. Alemão  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.